about
Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2.A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis.A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosisModifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping resultsThe orientation of eosin-5-maleimide on human erythrocyte band 3 measured by fluorescence polarization microscopyOligomeric state of human erythrocyte band 3 measured by fluorescence resonance energy homotransfer.Flexibility of the cytoplasmic domain of the anion exchange protein, band 3, in human erythrocytesVariation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.Cat and dog exposure and respiratory morbidities in cystic fibrosis.Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort studyUnderstanding the population structure of North American patients with cystic fibrosisInteractions between secondhand smoke and genes that affect cystic fibrosis lung diseaseDiabetes-related mortality in adults with cystic fibrosis. Role of genotype and sexGenome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.Quantitative imaging of green fluorescent protein in cultured cells: comparison of microscopic techniques, use in fusion proteins and detection limits.Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosisGenetic modifiers of cystic fibrosis-related diabetesDeep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits.Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.Hyperglycemia in Young Children with Cystic Fibrosis.
P50
Q28943477-B5C42C8C-8BD3-4000-9516-BFA257796A4AQ30425302-6C9685E0-E1BE-495F-BE1A-8266D75CB77EQ30426239-6D7BEA1C-2D3B-4420-86BF-57ED98C2FE12Q33869527-3B1843F5-F94C-4AED-8E5A-20D7578E74C9Q33880999-1DE4BB03-EA4C-4A78-9C49-2485CC7DF323Q33926291-2B144F34-60BD-4E3C-BC26-497D0AE36CAAQ34040104-43569ECF-606C-444F-988D-63BBB5791E10Q34168785-AB7214AB-5AB6-4A27-A3B0-0681B0FFE743Q34177028-229A72EB-D1FA-485F-B77A-AB40797129D6Q34205956-4068A0E6-16DD-449D-85EB-77E233A69C33Q34243590-5CE25F1E-1D94-4447-98D3-FBEEF8514894Q34254389-0B32CE4B-17DA-44ED-9573-A9CF368C09F2Q34333563-C205CE3D-500D-4E83-9F0F-250BEABD4A11Q34367715-BEA8986F-B4E9-441B-9288-7B7C5B271FE7Q35114878-DBECF923-316F-4D5D-AF47-D14ABBC006E3Q35140718-CFE8A7BF-926D-486A-91AF-27BDA28FD560Q36108378-47D456AB-A4D3-429D-A604-80C98B1B8B7AQ36788420-B3847E48-951E-4373-B3E1-00144DF62A99Q36929794-EBB36088-440A-479D-AA78-0505DB121C19Q37193385-0A998BC7-08DE-4BB1-8882-06C9924CDCE1Q37433652-771E306C-F921-4731-8FF6-0AF634819D9CQ44919962-4B8310BF-2427-49A5-A30C-B568D8D44B18Q48301569-9EFC1F44-A256-4377-87DC-8BC629468133
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Scott M Blackman
@ast
Scott M Blackman
@en
Scott M Blackman
@es
Scott M Blackman
@nl
type
label
Scott M Blackman
@ast
Scott M Blackman
@en
Scott M Blackman
@es
Scott M Blackman
@nl
prefLabel
Scott M Blackman
@ast
Scott M Blackman
@en
Scott M Blackman
@es
Scott M Blackman
@nl
P106
P31
P496
0000-0002-4532-6421